Do you really think, given where this drug is righ

Do you really think, given where this drug is right now, that a company owed some payment that might be late is going to call their lawyer and sue cytodyn - eliminating any chance of ever getting paid? Do you think that the large investors and BOD's that put up their money are just going to give up and walk away 1 month from BLA? That is really hard to believe. Once BLA is submitted - the inventory of Leronlimab has asset value with which loans can be made against. There is no chance this stops at this point. The reason he SP is in the crapper is because the big money investment is direct to the company, not buying on the OTC. The only buying on the OTC is us non-accredited investors. We have the task of soaking up the shares that warrant holders sell to mitigate risk. There are more of them than there of us. When this company gets just one deal done, the dependence on the OTC share price for funding evaporates. When the BLA is filed the cash necessary to operate comes from a loan payable at low interest rates and no dilution. This quarter is a huge change and it is right in front of us - the heavy lifting is done.